Seminal-Plasma Molecular Biomarkers as a Liquid Biopsy of Testicular Function: Toward AI-Ready Sperm-Retrieval Prediction in Non-Obstructive Azoospermia
International Journal of Molecular Sciences · 02.07.2026 · 27 (13) · 5965
DOI: 10.3390/ijms27135965 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.07.2026. Verfasst von Aris Kaltsas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece. Hauptthemen laut MEDLINE: Azoospermia, Semen, Biomarkers, Sperm Retrieval. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Non-obstructive azoospermia (NOA) is characterized by focal and quantitatively limited spermatogenesis, making preoperative prediction of sperm retrieval difficult. Seminal plasma is a biologically plausible liquid-biopsy compartment because it contains testicular, epididymal and accessory-gland secretions enriched with extracellular vesicles, cell-free nucleic acids, proteins and metabolites. This narrative molecular review examines the mechanisms by which germ-cell-derived molecular cargo reaches the ejaculate and organizes seminal-plasma biomarkers by cargo class and spermatogenic stage. Particular attention is given to extracellular-vesicle non-coding RNAs, cell-free seminal mRNAs, germ-cell-enriched proteins including TEX101 and ECM1, and metabolomic and lipidomic signatures. Although several markers show promising discrimination, most remain discovery-stage, single-center and insufficiently validated. The central argument is that the field should move from isolated biomarker nomination toward locked, stage-mapped multi-analyte panels integrated with clinical and genetic predictors under modern prediction-model standards. Seminal plasma is best viewed not as a ready clinical test, but as a biologically coherent platform for future calibrated, externally validated and artificial-intelligence (AI)-ready sperm-retrieval decision support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Third Department of Urology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
ORCID-Profile: Aris Kaltsas, Andreas Koumenis
Zitieren
APA
Kaltsas, A., Gasparos, F., Koumenis, A., Stavropoulos, M., & Chrisofos, M. (2026). Seminal-Plasma Molecular Biomarkers as a Liquid Biopsy of Testicular Function: Toward AI-Ready Sperm-Retrieval Prediction in Non-Obstructive Azoospermia. International Journal of Molecular Sciences, 27(13), 5965. https://doi.org/10.3390/ijms27135965
Vancouver
Kaltsas A, Gasparos F, Koumenis A, Stavropoulos M, Chrisofos M. Seminal-Plasma Molecular Biomarkers as a Liquid Biopsy of Testicular Function: Toward AI-Ready Sperm-Retrieval Prediction in Non-Obstructive Azoospermia. International Journal of Molecular Sciences. 2026;27(13):5965. doi:10.3390/ijms27135965
BibTeX
@article{Kaltsas2026,
author = {Kaltsas, Aris and Gasparos, Fotios and Koumenis, Andreas and Stavropoulos, Marios and Chrisofos, Michael},
title = {Seminal-Plasma Molecular Biomarkers as a Liquid Biopsy of Testicular Function: Toward AI-Ready Sperm-Retrieval Prediction in Non-Obstructive Azoospermia},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5965},
doi = {10.3390/ijms27135965}
}
EUVIMED